Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.

C Gaggiano, J Sota*, A Insalaco, R Cimaz, M Alessio, M Cattalini, R Gallizzi, Maggio MC, G Lopalco, Torre F La, C Fabiani, M Pardeo, Olivieri AN, P Sfriso, C Salvarani, S Grosso, C Bracaglia, Benedetti F De, Donato Rigante, L Cantarini

*Autore corrispondente per questo lavoro

Risultato della ricerca: Contributo in rivistaArticolo

Abstract

We have evaluated drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis. Our findings suggest an excellent overall drug retention rate for both anakinra and canakinumab that might be further augmented by paying attention to adverse events and employing these agents as first-line biologics in an early disease phase.
Lingua originaleInglese
pagine (da-a)1-2
Numero di pagine2
RivistaPEDIATRIC RHEUMATOLOGY ONLINE JOURNAL
Volume10th Congress of International Society of Systemic Auto-Inflammatory Diseases (ISSAID)
Numero di pubblicazione17 (Suppl 1)
DOI
Stato di pubblicazionePubblicato - 2019

All Science Journal Classification (ASJC) codes

  • Farmacologia
  • Farmacologia (medica)

Keywords

  • Juvenile idiopathic arthritis

Fingerprint

Entra nei temi di ricerca di 'Drug retention rate and predictive factors of drug survival for interleukin-1 inhibitors in systemic juvenile idiopathic arthritis.'. Insieme formano una fingerprint unica.

Cita questo